HANNAH MOORHEAD: Open Payments
NPI 1801469556 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 18 payments from 13 companies in 2025. Trend: 2023 $1,596 · 2024 $2,131 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $54 |
| Amgen Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $45 |
| ABBVIE INC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Seqirus USA Inc | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABIOMED | 1 | $22 |
Products named: OTEZLA, JARDIANCE, TRELEGY ELLIPTA, Wegovy, Fluad, HETLIOZ, CAPLYTA, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
